Every material Form 8-K Aspen Neuroscience, Inc. has filed with the SEC since November 02, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Aspen Neuroscience, Inc. completed its initial public offering on November 2, 2026, selling 9,375,000 shares of common stock at $15.00 per share. The company said gross proceeds were approximately $140.6 million, before underwriting discounts, commissions and offering expenses. Its amended and restated certificate of incorporation and bylaws also took effect on the same date.
IPO of 9,375,000 common shares at $15.00 per share, completed November 2, 2026
Gross proceeds of approximately $140.6 million, before underwriting discounts and offering expenses
Amended and restated certificate of incorporation and bylaws became effective at closing
Registration Statement on Form S-1 was filed October 9, 2026; final prospectus filed October 30, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Aspen Neuroscience, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →